Difference between revisions of "Alfonso Cepeda-Emiliani"
Jump to navigation
Jump to search
WikiModEn2 (talk | contribs) (Add LINKS section.) |
WikiModEn2 (talk | contribs) m |
||
| Line 1: | Line 1: | ||
| − | '''{{FULLPAGENAME}}''' serves on the [https://www.usc.gal/en/building/faculty-medicine-and-dentistry-medicine Faculty of Medicine and Dentistry] of the {{UNI|University of Santiago de Compostela|USC}}. He is the lead researcher into the innervation of the human [[penis]]. | + | Professor '''{{FULLPAGENAME}}''' serves on the [https://www.usc.gal/en/building/faculty-medicine-and-dentistry-medicine Faculty of Medicine and Dentistry] of the {{UNI|University of Santiago de Compostela|USC}}. He is the lead researcher into the innervation of the human [[penis]]. |
{{PUB}} | {{PUB}} | ||
Revision as of 18:01, 2 October 2025
Professor Alfonso Cepeda-Emiliani serves on the Faculty of Medicine and Dentistry of the University of Santiago de Compostela. He is the lead researcher into the innervation of the human penis.
Publications
Cepeda-Emiliani A, Gándara-Cortés M, Otero-Alén M, García H, Suárez-Quintanilla J, García-Caballero T, Gallego R, García-Caballero R. Immunohistological study of the density and distribution of human penile neural tissue: gradient hypothesis. Int J Impot Res. 2 May 2023; 35(3): 286-305. PMID. DOI. Retrieved 21 November 2023.- Cepeda-Emiliani A, Otero-Alén M, García-Caballero T, et al. The Human Mechanosensory Corpuscles: A New Schwann Cell Localization of the Wilms’ Tumor Protein WT1. J Histochem Cytochem. May 2025; 73(5-6): 197-221. PMID. PMC. DOI. Retrieved 3 October 2025.
- Cepeda-Emiliani A, Otero-Alén M, Suárez-Quintanilla J, Gándara-Cortés M, García-Caballero T, García-Caballero R, García-Caballero L. The sensory penis: A comprehensive immunohistological and ontogenetic exploration of human penile innervation. Andrology. 19 September 2025; : 1-41. PMID. DOI. Retrieved 1 October 2025.
External links
Thompson, Troy (15 August 2025). New Danger to Intact Men: Penile Neurotomy
, GALDEF. Retrieved 3 October 2025.
